Products for Research Use Only
RegisterLogin

CDK8-IN-20

CAT: 0013-GTR19274269-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19274269-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK8-IN-20 (Compound 67j) is a highly selective and potent type I CDK8 inhibitor with oral bioavailability, exhibiting an IC50 value of 70.5 nM. The IC50 values for its action on homologous kinases CDK19, CDK7, and CDK9 are 147.8, 726.9, and 217.4 nM, respectively. CDK8-IN-20 effectively inhibits the proliferation of HCT-116, HT-29, and SW-480 cells with IC50 values of 5.9, 17.93, and 9.52 μM, respectively, while demonstrating low cytotoxicity toward normal gastric mucosal epithelial cells (GES-1) with an IC50 greater than 100 μM. It disrupts the Wnt/β-catenin pathway, downregulating β-catenin, Cyclin D1, and c-Myc expression. Additionally, CDK8-IN-20 induces reactive oxygen species (ROS) production and leads to G2/M phase and S phase cell cycle arrest. This compound is applicable in cancer research, such as colorectal cancer.
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19203844-01CDK8-IN-3
GTR18584073-01CDK8 Antibody
GTR18579723-01CDK8 Antibody
GTR19186298-01CDK8-IN-5
GTR19061791CDK8 Peptide
GTR18022091Cdk8 Antibody
GTR18236783-01CDK8 Antibody
GTR18140208Cdk8 Antibody
GTR19213052-01CDK8-IN-12
GTR19209843-01CDK8-IN-4k

Alternative Products

CatalogName
521352-01CDK8
BA3104-5CDK8-IN-13
BA3810-10CDK8-IN-1
BA3859-1CDK8-IN-12
70R-31732CDK8 antibody
464161CDK8/19i
HY-151463-01CDK8-IN-11
HY-147716CDK8-IN-6
HY-171174-01CDK8-IN-16
HY-162600CDK8-IN-15

Popular Products